ALT

2.90

1.02% -0.03

Pre-mercato: 2.94 0.04 +1.38%

Altimmune Inc (ALT)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario Storia dei dividendi

Precedente Chiudi:

$2.93

Aprire:

$2.94

Volume 24 ore:

1.99M

Relative Volume:

0.51

Capitalizzazione di mercato:

$563.98M

Reddito:

$41,000

Utile/perdita netta:

$-88.09M

Rapporto P/E:

-2.856

EPS:

-1.0154

Flusso di cassa netto:

$-67.55M

1 W Prestazione:

+1.75%

1M Prestazione:

-16.43%

6M Prestazione:

-39.71%

1 anno Prestazione:

-49.74%

Intervallo 1D:

$2.88

$3.00

Intervallo di 1 settimana:

$2.72

$3.00

Portata 52W:

$2.56

$7.73

Altimmune Inc Stock (ALT) Company Profile

Nome

Altimmune Inc

Settore

Healthcare (1106)

Industria

Biotechnology (618)

Telefono

(240) 654-1450

Indirizzo

910 CLOPPER ROAD, GAITHERSBURG, MD

Dipendente

Cinguettio

Prossima data di guadagno

2026-05-13

Ultimi documenti SEC

ALT's Discussions on Twitter

Compare ALT vs VRTX, REGN, ARGX, ALNY, RVMD

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ALT Altimmune Inc	2.90	569.81M	41,000	-88.09M	-67.55M	-1.0154
VRTX Vertex Pharmaceuticals Inc	434.52	110.03B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	638.88	67.37B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	806.46	50.76B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	297.45	40.12B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	151.56	32.68B	742.00K	-1.37B	-1.07B	-7.0731

Altimmune Inc Stock (ALT) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-04-24	Aggiornamento	Goldman	Sell → Neutral
2026-03-18	Iniziato	Truist	Buy
2026-01-28	Iniziato	Barclays	Overweight
2025-07-10	Ripresa	Goldman	Sell
2025-02-28	Iniziato	William Blair	Mkt Perform
2025-01-08	Iniziato	Stifel	Buy
2024-11-12	Iniziato	UBS	Buy
2024-04-29	Downgrade	Guggenheim	Buy → Neutral
2024-01-24	Iniziato	Goldman	Neutral
2023-03-22	Downgrade	Goldman	Buy → Neutral
2022-12-01	Iniziato	Goldman	Buy
2021-12-29	Ripresa	Jefferies	Buy
2021-06-02	Iniziato	H.C. Wainwright	Buy
2021-02-11	Iniziato	Guggenheim	Buy
2020-12-14	Iniziato	Jefferies	Buy
2020-11-12	Reiterato	B. Riley Securities	Buy
2020-09-25	Iniziato	B. Riley FBR	Buy
2020-08-14	Iniziato	Evercore ISI	Outperform
2020-07-31	Iniziato	Piper Sandler	Overweight
2020-07-28	Iniziato	JMP Securities	Mkt Outperform
2020-02-24	Ripresa	ROTH Capital	Buy
2019-07-19	Iniziato	ROTH Capital	Buy
2017-10-09	Iniziato	Piper Jaffray	Overweight

Mostra tutto

Altimmune Inc Borsa (ALT) Ultime notizie

May 25, 2026

H.C. Wainwright cuts Altimmune stock price target on dilution - Investing.com India

May 19, 2026

H.C. Wainwright cuts Altimmune stock price target on dilution By Investing.com - Investing.com South Africa

May 19, 2026

H.C. Wainwright Maintains Altimmune(ALT.US) With Buy Rating, Maintains Target Price $20 - Moomoo

May 19, 2026

Several Insiders Invested In Altimmune Flagging Positive News - simplywall.st

May 19, 2026

May 18, 2026

ALT Maintained by HC Wainwright & Co. -- Price Target Lowered to $20 - GuruFocus

May 18, 2026

H.C. Wainwright Maintains Altimmune(ALT.US) With Buy Rating, Cuts Target Price to $20 - Moomoo

May 18, 2026

Altimmune Price Target Cut to $20.00/Share From $25.00 by HC Wainwright & Co. - Moomoo

May 18, 2026

Altimmune Inc Price USD, ALT Price Live Charts, Market Cap & News - Bitget

May 18, 2026

May 16, 2026

ALT: Altimmune Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits

May 16, 2026

May 15, 2026